儿童患者睡眠呼吸障碍与喘控制之间的复杂联系:一个横截面研究
Cristian Locci1, Mariangela V Puci2, Laura Saderi2
1Pediatric Clinic, Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
Respiratory medicine
|July 4, 2024
概括
睡眠呼吸障碍 (SDB) 在患有喘的儿童中很常见,影响他们的喘控制和生活质量 (QoL). 失控的喘增加了SDB风险,需要进一步调查.
科学领域:
- 儿科肺病学 儿科肺病学
- 睡眠医学 睡眠医学
- 过敏和免疫学 过敏和免疫学
背景情况:
- 儿童的喘和睡眠呼吸障碍 (SDB) 可能会对生活质量 (QoL) 产生负面影响.
- SDB也可能使儿童喘的有效管理复杂化.
研究的目的:
- 确定喘儿童中SDB的流行率.
- 评估SDB和喘控制之间的关联.
- 确定SDB的风险因素,并评估喘控制和SDB对QOL的影响.
主要方法:
- 招募了78名喘儿童 (年龄在5-12岁).
- 使用儿科睡眠问卷 (PSQ) 评估SDB.
- 通过儿童喘控制测试 (C-ACT) 评估喘控制,并通过儿科生活质量库存 (PedsQL) 评估QoL.
主要成果:
- SDB患病率为37.2%,在患有未控制喘的儿童中 (60.1%) 与控制良好喘 (27.3%) 相比显著更高.
- 没有控制的喘 (C-ACT ≤19) 显示SDB的风险增加了4.15倍.
- 患有SDB的喘儿童的C-ACT和PedsQL得分较低,表明喘控制和QoL较差.
结论:
- SDB显著影响儿童的喘控制和QoL.
- 患有非控制性喘的喘儿童患SDB的风险更高.
- 对于患有非控制性喘的喘儿童,建议推进行多睡眠摄影,以排除潜在的SDB.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
381
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Other Pulmonary Disorders
815
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
815


